Heron Therapeutics Reports Q3 2026 Loss of $5.0 Million with Revenue of $35. ...

GuruFocus | Nov 9, 2026 8:31 AM EST

Acute Care Franchise Growth Offset by Oncology Decline as Heron Agrees to Asset Sale to CorMedix Related Stocks: HRTX ,